About Flaskworks
Flaskworks is a company based in Boston (United States) founded in 2016 by Shashi Murthy was acquired by Northwest Biotherapeutics in September 2020. Flaskworks has raised $750 thousand across 3 funding rounds from investors including Northwest Biotherapeutics and National Science Foundation. Flaskworks operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Boston, United States
- Founders Shashi Murthy
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$750 K (USD)
in 3 rounds
-
Latest Funding Round
$750 K (USD), Grant
Sep 01, 2019
-
Investors
Northwest Biotherapeutics
& 1 more
-
Employee Count
Not available
-
Acquired by
Northwest Biotherapeutics
(Sep 01, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Flaskworks
Unlock access to complete
Unlock access to complete
Funding Insights of Flaskworks
Flaskworks has successfully raised a total of $750K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $750 thousand completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Flaskworks
Flaskworks has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Northwest Biotherapeutics and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked | |
|
Dendritic cell-based vaccines for prostate and brain cancers are developed.
|
Locked | Locked | Locked |
Investor details for Flaskworks
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Flaskworks
Investment portfolio details for Flaskworks
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Flaskworks
Detailed financials for Flaskworks
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Flaskworks Comparisons
Peer comparison for Flaskworks
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Flaskworks
Flaskworks operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Flaskworks
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Flaskworks
Complete news archive for Flaskworks
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Flaskworks
Flaskworks was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Flaskworks is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Jennifer Rossi is the current CEO of Flaskworks.
Flaskworks is a funded company, having raised a total of $750K across 3 funding rounds to date.
Flashwork manufactures immunotherapeutics for research purposes. The products are MicroDen system for dendritic cell generation and have applications in biologics discovery, characterization for human, and non-human cells. Baton is a clinical-stage manufacturing system for suspension cells.
Flaskworks's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Flaskworks has 2 investors. Key investors include Northwest Biotherapeutics, and National Science Foundation.